[BONUS] Dear Cancer: What Is Biomarker Testing?

[audio mp3="https://pdcn.co/e/rss.art19.com/episodes/f6d58efa-6beb-4af0-a508-175d9819eb3e.mp3?rss_browser=BAhJIgljdXJsBjoGRVQ%3D--435795d5c850773aaa4739d968bd77a1dfd6f301"][/audio]

Welcome to "Dear Cancer," a takeover episode of Out of Patients with special guest hosts Dr. Mark Lewis, an oncologist from Intermountain Medical Center, and Stephanie Elsea, a volunteer patient advocate from The Lustgarten Foundation. Together with Matthew Zachary, Mark and Stephanie break down the latest cancer research medical jargon into human terms, especially with the help of another special guest, Matt's daughter, Hannah. With grace, humor, and passion, the three share personal stories that connect them deeply to this cause. They wish only to help patients strike that balancing act between hope and hope by banishing pessimism and embracing reality about their prognoses. Throughout the episode, the team covers everything from understanding different types of tumors, what biomarkers are (and their importance), and clinical trials can sound less, um.. "clinical." They also discuss the latest findings and some extremely positive results from the Crestone Research Study.

See if biomarker testing is right for you, and sign up today at http://dearcancer.health/findout.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.